dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Invitation

Sotsiaalministeerium · 15. november 2019
Viit
1.4-4/2793-1
Registreeritud
15. november 2019
Dokumendi liik
Sissetulev kiri
Adressaat
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2019
Vastutaja
Liisa Lents (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
27. november 2019

Failid

  • 📎E-kiri.pdf725 KB
  • 📎EMCDDA_24_19_rev1_Draft_Agenda MB 12-13 December 2019_181019.docx61 KB
  • 📎Invitation_MB December 2019_Annex_Practical details_en_final.docx56 KB
  • 📎Invitation_MB December 2019_members_de_311019.docx61 KB
  • 📎Invitation_MB December 2019_members_en_311019.docx62 KB
  • 📎Invitation_MB December 2019_members_fr_311019.docx60 KB

Sisu (failidest)

-50165 -608331 EMCDDA/ 24 / 1 9 rev1 0 0 EMCDDA/ 24 / 1 9 rev1 431800 467995 0 0 Agenda I Management Board 60 th Meeting Date 12 – 13 December 201 9 C hair Laura d’Arrigo Venue Lisbon Thur sday, 12 December 201 9 9 .30– 13 . 0 0 Adoption of the agenda EMCDDA/ 24 / 1 9 rev 1 Annotated agenda EMCDDA/ 25 / 19 Ac tivity reports : Report on the activities of the Chair EMCDDA/ 26 / 19 Report from the Budget Committee EMCDDA/ 27 / 19 Report on the external activities of the Director EMCDDA/ 28 / 19 Presentations by the EU Presidencies : Presentation on the conclusions of the Finnish Presidency Presentation on the programme of the Croatian Presidency Budget and financial issues : Multiannual Financial Framework for 20 21 – 20 27 : oral update by the European Commission (for information) Budget for 2020 (for adoption) EMCDDA/ 29 /1 9 Preliminary draft budget for 2021 (for adoption) EMCDDA/ 30 /1 9 Performance , planning and internal controls: Programming document for 2020-22 and work programme for 2020 (for adoption) EMCDDA/ 3 1 /1 9 Preliminary draft Programming Document for 2021-23 and preliminary draft work programme for 2021 (for adoption) EMCDDA/ 3 2 /1 9 EMCDDA Action Plan to follow up on the recommendations of the EMCDDA’s external evaluation (for decision) EMCDDA/ 33 /1 9 13.00– 14.30 Lunch 14.30 – 17.00 State of implementation of the recommendations issued by the Internal Audit Service (IAS ) (for information) EMCDDA/ 3 4 /1 9 IAS Strategic Audit Plan 2020-22 for the EMCDDA (for endorsement) EMCDDA/ 3 5 /1 9 International cooperation : Cooperation with non-EU countries, international organisations and other EU agencies: recent developments (for information) EMCDDA/ 3 6 /1 9 Candidate and potential candidate countries: Working arrangement between the EMCDDA and Serbia (for decision) EMCDDA/ 3 7 /1 9 European Neighbourhood Countries: ‘EU4 Monitoring Drugs’ project (for information) EMCDDA/ 3 8 / 19 The EMCDDA / IPA 7 project (Instrument for Pre-Accession Assistance) (for information) EMCDDA/ 39 / 19 Reitox network : State of play of the implementation of the Reitox Development Framework (for information) EMCDDA/ 40 / 19 Measures to improve the management of the c o-financing of the Reitox network (for information ) EMCDDA/ 4 1 / 19 F ri day, 13 December 201 9 9.30– 1 3 . 0 0 Restricted session: Renewal of the mandate of the EMCDDA Director : oral state of play of the procedure (for information ) E lection of one Budget Committee member (for decision) EMCDDA/ 42 /19 Appointment of the members of the Scientific Committee and establishment of a reserve list (for decision) EMCDDA/ 43 /19 Approval of the list of experts to extend the Scientific Committee for the purposes of the risk assessment of new psychoactive substances (for decision) EMCDDA/ 44 /19 Drug situation in Europe : Main findings of the third joint EMCDDA-Europol E U Drug Markets Report (for information) EMCDDA/45/19 Cocaine challenges in the EU: t rends in production , trafficking and use (for discussion) Launch and uptake of the third joint EMCDDA-Europol E U Drug Markets Report (for information) EMCDDA/ 46 /19 Review of the European Drug R eport package (for information ) EMCDDA/ 47 /19 Data protection and prevention and management of conflicts of interest: Periodic assessment of the implementation of the EMCDDA Policy for the prevention and management of conflicts of interest for Management Board members, substitutes and observers (for decision) EMCDDA/ 48 /1 9 Any other business Third European Conference on addictive behaviours and dependencies (Lisbon, 23-25 October 2019): conclusions by the Portuguese delegation (for information ) EMCDDA/ 49 /1 9 Saatja: Anna-Liisa Pääsukene <[email protected]> Saadetud: 13.11.2019 10:26 Adressaat: Mall Hiet <[email protected]> Teema: FW: Invitation EMCDDA Management Board meeting, 12-13 December 2019 Manused: image001.gif; Invitation_MB December 2019_members_en_311019.docx; Invitation_MB December 2019_members_fr_311019.docx; Invitation_MB December 2019_members_de_311019.docx; Invitation_MB December 2019_Annex_Practical details_en_final.docx; EMCDDA_24_19_rev1_Draft_Agenda MB 12-13 December 2019_181019.docx Tere! Kas saaksid palun allpool oleva kirja Deltas registreerida. Mul endal täna viimane tööpäev ja ma ei saa osaleda, aga samas keegi SoM-ist võiks. Aitäh! Anna-Liisa From: Elsa Costa <[email protected]> Sent: Tuesday, November 12, 2019 1:07 PM To: Hidden - Maria Afxentiou <[email protected]>; ALVAREZ MARTÍN Elena ([email protected]) <[email protected]>; AZUCENA MARTÍ PALACIOS María ([email protected]) <[email protected]>; BAYER Raphael ([email protected]) <[email protected]>; BELIAN Grazina ([email protected]) <[email protected]>; BUKOWSKA Boguslawa ([email protected]) <[email protected]>; BUKOWSKA Boguslawa ([email protected]) <[email protected]>; CARDOSO Manuel ([email protected]) <[email protected]>; CARLSON Johan ([email protected]) <[email protected]>; Chair MB <[email protected]>; CLARK Marilyn ([email protected]) <[email protected]>; Hidden - Lauren Comber <[email protected]>; Hidden - Maria Contento <[email protected]>; CSAKO Ibolya ([email protected]) <[email protected]>; Hidden - Laura d'Arrigo <laura.d- [email protected]>; DEBNAROVA Eva ([email protected]) <[email protected]>; DENCKER Sofie ([email protected]) <[email protected]>; DUTA Cristian ([email protected]) <[email protected]>; GILLARD Claude ([email protected]) <[email protected]>; GÖTZ Wolfgang ([email protected]) <[email protected]>; Hidden - João Goulão <[email protected]>; HREN Joze ([email protected]) <[email protected]>; JABLONSKI Piotr ([email protected]) <[email protected]>; JUOZAPAVICIENE Inga ([email protected]) <[email protected]>; KALAMARZ Wojciech ([email protected]) <[email protected]>; KEENAN, Eamon ([email protected]) <[email protected]>; KISSOVA Lucia ([email protected]) <[email protected]>; KOTOVIRTA Elina ([email protected]) <[email protected]>; KOUIMTSIDIS Christos ([email protected]) <[email protected]>; KOUIMTSIDIS Christos ([email protected]) <[email protected]>; LOBODASOVA Nadežda ([email protected]) <[email protected]>; MALLIORI Meni ([email protected]) <[email protected]>; MALLIORI Meni ([email protected]) <[email protected]>; MARTENS Vladimir ([email protected]) <[email protected]>; MARTENS Vladimir ([email protected]) <[email protected]>; MELIN Henrik ([email protected]) <[email protected]>; MICHOU Paraskevi ([email protected]) <[email protected]>; MIKULIC Sanja ([email protected]) <[email protected]>; MORTLER Marlene ([email protected]) <[email protected]>; MORTLER Marlene ([email protected]) <[email protected]>; MOZGIS Dzintars ([email protected]) <[email protected]>; MUSCAT Richard ([email protected]) <[email protected]>; MUSCHEL Laurent ([email protected]) <[email protected]>; NEGOITA Constantin ([email protected]) <[email protected]>; NEGOITA Constantin ([email protected]) <[email protected]>; O'CONNOR Rosanna (Rosanna.O'[email protected]) <Rosanna.O'[email protected]>; ONIDI Olivier ([email protected]) <[email protected]>; Hidden - Alain Origer <[email protected]>; PAASO Kari ([email protected]) <[email protected]>; Anna-Liisa Pääsukene <[email protected]>; PAPANASTASATOS Gerasimos ([email protected]) <[email protected]>; PEIL Ain ([email protected]) <[email protected]>; PETERSEN Lars ([email protected]) <[email protected]>; PETKOVIC Zeljko ([email protected]) <[email protected]>; PETRIC Vesna-Kerstin (Vesna- [email protected]) <[email protected]>; PIETSCH Franz ([email protected]) <[email protected]>; PIETSCH Jörg ([email protected]) <[email protected]>; POOS Xavier ([email protected]) <[email protected]>; POPOV Plamen (pl.popov@ncn- bg.org) <[email protected]>; PRISSE Nicolas ([email protected]) <[email protected]>; SANNES Victor ([email protected]) <[email protected]>; SERGIDES Stelios ([email protected]) <[email protected]>; SERGIDES Stelios ([email protected]) <[email protected]>; Hidden - Elisabetta Simeoni <[email protected]>; SIMEONI Elisabetta ([email protected]) <[email protected]>; SIPALA Floriana ([email protected]) <[email protected]>; SZASZIK Monika ([email protected]) <[email protected]>; VEDRALOVÁ Jarmila ([email protected]) <[email protected]>; WALSH Jim ([email protected]) <[email protected]>; ZABRANSKY Tomas ([email protected]) <[email protected]>; OTTESEN Lilly <[email protected]>; OTTESEN Lilly Sofie <[email protected]>; Hidden - Sarıgüzel Murat <tr- [email protected]>; BRETTEVILLE-JENSEN Anne Line ([email protected]) <[email protected]>; Hidden - Lies Gremeaux <[email protected]>; FERREIRA BORGES Carina ([email protected]) <[email protected]>; GERRA Gilberto ([email protected]) <[email protected]>; HUBER Denis ([email protected]) <[email protected]> Cc: Alexis Goosdeel <[email protected]>; Brandt Stephan ([email protected]) <[email protected]>; Hidden - [email protected] <[email protected]>; Dante Storti <[email protected]>; DELVAUX Merryl ([email protected]) <[email protected]>; DYBOWSKI Sandra <[email protected].>; Elsa Costa <[email protected]>; Fabian Pereyra <[email protected]>; Hidden - Edith Hofer <[email protected]>; Magdalena Popova <[email protected]>; Monika Blum <[email protected]>; Hidden - Sofia Santos <[email protected] saude.pt>; SIEGL Julian ([email protected]) <[email protected]> Subject: Invitation EMCDDA Management Board meeting, 12-13 December 2019 For the attention of the members, substitutes and observers of the Management Board Please find attached the invitation letter and draft agenda for the next Management Board meeting, which will take place on 12-13 December 2019. Kind regards. (s.) Laura d'Arrigo Chair of the Management Board Elsa Costa Administrative assistant Directorate Tel. (351) 211 21 02 88 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, Portugal • www.emcdda.europa.eu This message and any attachment contain information which may be sensitive or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately. Please consider the impact on the environment before printing this email. PRACTICAL DETAILS The fifty- seven th meeting of the Management Board of the European Monitoring Centre for Drugs and Drug Addiction will take place from Thursday 1 2 to Friday 13 December 201 9 at the EMCDDA Headquarters, Praça Europa 4, Cais do Sodré , 1249-289 Lisbon (phone number: +351 211 21 02 8 8 ). The meeting will begin on 1 2 December at 9.30 and will end at 13 .00 on 13 December . Simultaneous translation will be provided in French, English, German . Board members will be able to express themselves also in Croatian, Polish and Portuguese if they so wish. In conformity with Article 9 of the rules of procedure of the Management Board, the members are requested to inform by e-mail ( [email protected] ) of their presence at the meeting until Friday, 22 November 201 9 . It is of the utmost importance that the members of the Board or their substitutes which notify their presence to the meeting are attending the whole meeting and are present until the closure of meeting, so that decisions can be taken by the Board according to Article 11 of the rules of procedure. Members and substitutes: Members are kindly asked to contact the secretariat for flights as soon as possible but to arrange their own accommodation. In accordance with the decision taken by the Management Board in January 2005, the travel expenses of only one representative by country will be reimbursed (see note attached). As a rule participants should use EMCDDA pre-paid tickets. In exceptional cases, when members take care themselves of their flights, they are kindly requested to use ‘economic class’ tickets, ‘business class’ tickets will not be reimbursed. Please be informed that documents for reimbursements not provided during the meeting must be received at the EMCDDA within a maximum of three months after the date of the meeting . Chair of the Scientific Committee: You are kindly asked to inform Ms Elsa Costa by e-mail ( [email protected] ) of your presence at the meeting, and for your preferences concerning travel arrangements. EMCDDA pre-paid tickets should be used as a rule. In exceptional cases, members are kindly requested to use ‘economic class’ tickets, ‘business class’ tickets will not be reimbursed (see note attached). Please be informed that documents for reimbursements not provided during the meeting must be received at the EMCDDA within a maximum of three months after the date of the meeting . Spokesperson of the Reitox national focal points: Please inform Ms Elsa Costa by e-mail ( [email protected] ) of your presence at the meeting, and for your preferences concerning travel arrangements. EMCDDA pre-paid tickets should be used as a rule. In exceptional cases, members are kindly requested to use ‘economic class’ tickets, ‘business class’ tickets will not be reimbursed (see note attached). Please be informed that documents for reimbursements not provided during the meeting must be received at the EMCDDA within a maximum of three months after the date of the meeting . Observers: Observers are kindly asked to arrange their own transport and accommodation. An die Mitglieder , stellvertretenden Mitglieder und Beobachter des Verwaltungsrates der E MCDDA Ref : DIR/ LA / mb (1 9 ) D 55 Dat um : Lissabon , den 12 . Novem ber 201 9 Betreff: Sechzi gste Sitzung des Verwaltungsrates der Europäischen Beobachtungsstelle für Drogen und Drogensucht Ich freue mich, Sie zur sech zigste n Sitzung des Verwaltungsrates der Europäischen Beobachtungsstelle für Drogen und Drogensucht , die vom Donnerstag , dem 1 2 . um 9.30 Uhr bis zum Freitag, dem 1 3 . Dezember 201 9 um 13.00 Uhr in der EMCDDA stattfinden wird, einzuladen . Anbei finden Sie die vorläufige Tagesordnung für dieses Treffen. Die Dokumente werden ab dem 2 7 . November auf der eigens für den Verwaltungsrat eingerichteten Website zu finden sein. Wie bereits in der letzten Sitzung im Juni angekündigt, möchte ich mit Ihnen die Herausforderungen und letzte Entwicklungen im Bereich der Produktion, des Handels und des Konsums von Kokain in der EU besprechen. Ich werde einige Delegationen einladen, ihre neuesten Erfahrungen zu diesem Thema kurz mit uns zu teilen. Die Europäische Kommission wird uns ebenfalls zum Stand der Verhandlungen zum Mehrjährigen Finanzrahmen für 2021 – 27 informieren. Weitere wichtige Punkte sind die Annahme des Programmplanungsdokument s der EMCDDA für 20 20 – 22 , sowie de s Vorentwurf s des Programmplanungsdokument s der EMCDDA für 2021 – 23 . Beide Programmplanungsdokument e werden vom vorläufigen Haushaltplan für 20 20 und vom Vorent wurf des Haushaltsplans für 20 2 1 begleitet. Anbei finden Sie die praktischen Informationen für di e Sitzung , um Ihnen bei der Organisation Ihrer Teilnahme hilfreich zu sein . Ich hoffe auf ein e erfolgreiche Sitzung und freue mich, Sie bald in Lissabon zu treffen . Mit freundlichen Grü ß en (s.) Laura d‘Arrigo Vorsitze nde des Verwaltungsrates A l’attention des membres , suppléants et observateurs du conseil d’administration de l’EMCDDA Ref : DIR/ LA /mb ( 1 9 ) D 55 Date: 12 novembre 2019 Obje t: Soixantième réunion du Conseil d'administration de l'Observatoire européen des drogues et des toxicomanies Chers collègues , J’ai le p laisir de vous inviter à la prochaine réunion du Conseil d’administration de l’Observatoire des drogues et des toxicomanies, qui aura lieu du jeudi 1 2 à 9.30 heures au vendredi 1 3 décembre 201 9 à 13.00 heures au siège de l’ agence. Vous trouverez ci-joint l e projet d ’ordre du jour de cette rencontre. L es documents seront disponibles sur le site restreint le 2 7 novembre . C onformément à ce qui a été annoncé lors de notre dernière réunion au mois de juin, je souhaiterais que nous puissions échanger sur le thème ‘Défis liés à la cocaïne dans l’UE: tendances en termes de production, trafic et usage’ . Dans cette optique, j’ai l’intention d’inviter certaines délégations à partager brièvement les tendances récentes au niveau national . Par ailleurs , la Commission présentera l es avancée s des négociations concernant l es Perspectives financières pluriannuelles 2021 – 27. L ’ adoption du document de programmation de l’EMCDDA pour la période 20 20 – 2 2 , et du projet de programme de travail pour la période 20 2 1 – 2 3 , représente nt d ’autr es points importants de cette réunion . Ces deux documents de programmation seront accompagnés du projet de budget pour 20 20 et de l’avant-projet d e budget pour 2021 . Vous trouverez en annexe tous les détails pratiques concernant la réunion , afin de faciliter votre participation à la réunion. Dans l’attente de vous retrouver tous à Lisbonne pour une réunion fructueuse, Avec mes salutations cordiales , (s.) Laura d’Arrigo Prés ident e du Conseil d’adm i nistration F or the attention of the members, substitutes and observers of the EMCDDA Management Board Ref : DIR/ LA /mb ( 1 9 ) D 55 Date: 12 Novem ber 201 9 Subject: Sixtie th meeting of the Management Board of the European Monitoring Centre for Drugs and Drug Addiction Dear colleagues, I am pleased to invite you to the next meeting of the Management Board of the European Monitoring Centre for Drugs and Drug Addiction to take place at the EMCDDA premises from Thur sday 12 December at 9.30 to Friday 13 December 201 9 at 13.00 . Please find enclosed to this correspondence the draft agenda for the meeting. D ocuments will be made available on the restricted website as from 27 November . Please note that , as announced at our last meeting in June, I would like to discuss with you the topic of ‘Cocaine challenges in the EU: trends in production, trafficking and use ’ . I t is my intention to invite some delegations to briefly share the latest trends at national level . Furthermore, t he European Commission will provide an update on the negotiations for the Multiannual Financial Framework for 2021 –27. T he adoption of the EMCDDA’s programming document covering the period 2020 – 2 2 , and of the draft programming document for 2021 –2 3 , represent other important items on the agenda. These two planning documents will be accompanied by the draft budget for 2020 and the preliminary draft budget for 2021 . Please find attach to this invitation all practical details needed to ease the organisation of your participation to the meeting . I look forward to meeting you all in Lisbon and to having a fruitful meeting. Yours sincerely, (s.) Laura d’Arrigo Chair of the Management Board
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel